Tag: Bruton’s tyrosine kinase

Calquence

AstraZeneca’s Calquence shows promising clinical improvement in Covid-19 patients

0
Results published in Science Immunology showed that Calquence (acalabrutinib), a Bruton’s tyrosine kinase (BTK) inhibitor, reduced markers of inflammation and improved clinical outcomes of...

This function has been disabled for HealthTekPak.

error: Content is protected !!